U.S. markets closed

Selecta Biosciences, Inc. (SELB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.4600-0.1300 (-3.62%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 7/31/2021
Current
3/31/202112/31/20209/30/20206/30/2020
Market Cap (intraday) 5
391.65M511.22M327.46M265.95M286.41M
Enterprise Value 3
279.19M407.88M216.54M232.82M242.53M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
13.1727.5923.4227.0625.40
Price/Book (mrq)
31.26N/AN/AN/AN/A
Enterprise Value/Revenue 3
10.1036.9118.1250.11N/A
Enterprise Value/EBITDA 7
-3.92-17.23-14.95-25.22-10.21

Trading Information

Stock Price History

Beta (5Y Monthly) 0.93
52-Week Change 331.06%
S&P500 52-Week Change 333.41%
52 Week High 35.7000
52 Week Low 31.4700
50-Day Moving Average 34.1056
200-Day Moving Average 34.0518

Share Statistics

Avg Vol (3 month) 31.18M
Avg Vol (10 day) 31.11M
Shares Outstanding 5113.19M
Implied Shares Outstanding 6N/A
Float 80.3M
% Held by Insiders 128.83%
% Held by Institutions 150.04%
Shares Short (Jul 14, 2021) 46.87M
Short Ratio (Jul 14, 2021) 47.52
Short % of Float (Jul 14, 2021) 410.31%
Short % of Shares Outstanding (Jul 14, 2021) 46.07%
Shares Short (prior month Jun 14, 2021) 46.96M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021

Profitability

Profit Margin -267.13%
Operating Margin (ttm)-163.33%

Management Effectiveness

Return on Assets (ttm)-21.26%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)27.65M
Revenue Per Share (ttm)0.26
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-37.91M
EBITDA -44.45M
Net Income Avi to Common (ttm)-73.85M
Diluted EPS (ttm)-0.7020
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)147.81M
Total Cash Per Share (mrq)1.31
Total Debt (mrq)35.36M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.93
Book Value Per Share (mrq)-0.17

Cash Flow Statement

Operating Cash Flow (ttm)34.45M
Levered Free Cash Flow (ttm)34.28M